Summary & Overview
Biopsies of Musculoskeletal System and Connective Tissue without CC/MCC: Inpatient Reimbursement Overview
DRG 479 encompasses inpatient admissions for biopsies of the musculoskeletal system and connective tissue without Major Complication or Comorbidity or Complication or Comorbidity; it defines the clinical scope for cases where diagnostic tissue sampling is the principal inpatient service. Correct classification matters for inpatient reimbursement because it determines bundled payment under the Centers for Medicare & Medicaid Services Inpatient Prospective Payment System and influences hospital claim adjudication and revenue.
DRG 479 Overview
DRG 479 covers inpatient admissions for biopsies of the musculoskeletal system and connective tissue when there is no Major Complication or Comorbidity and no Complication or Comorbidity. This Diagnosis-Related Group captures cases where diagnostic tissue sampling is the primary focus, often for evaluation of tumors, inflammatory processes, or unexplained lesions. It matters for Medicare payment because it groups similar resource use for reimbursement purposes under the Inpatient Prospective Payment System. Accurate assignment affects hospital revenue and claims processing under Centers for Medicare & Medicaid Services rules.